Læknablaðið - 15.04.1983, Blaðsíða 11

LÆKNABLAÐIÐ
103
digitalis glycosides in the Egilsstadir health district
and in Iceland could be even lower.
HEIMILDIR
1) Withering W. An Account of the Foxglove and
Some of its Medical Uses. Birmingham: Swin-
ney 1785.
2) Nordiska lakemedelsnamnden. Nordisk lákeme-
delsstatistik 1975-1977 Dei I, 121-3.
3) Sigurðsson G, Magnússon G, Sigvaldason H,
Tuliníus H, Einarsson I, Ólafsson Ó. Egilsstaðar-
rannsóknin. Sjúkraskrár fyrir heilsugæslustöðv-
ar og tölvufærsla upplýsinga. Fylgirit við heil-
brigðisskýrslur. Landlæknisembættið 1980.
4) Boman K, Ögren JE. Digitalis i öppen várd inom
Skellefteá sjukvárdsdistrikt. Lákartidningen
1981;78:3899-3901.
5) Jóelsson H. Lyfsali Egilsstöðum: Persónulegar
upplýsingar janúar 1982.
6) Bergman U, Sjöqvist F, Söderhielm L. Use of
Digoxin in a Low Density Population Area in
Sweden. Europ J Clin Pharmacol 1976; 10: 19-
24.
7) Agenás I, Ottoson E, Smedby B. Comparison
between two ways of measuring drug utilization
in the population. Manus 81 01 19.
8) Svensk lákemedelsstatistik 1980. Statistiska
sammanstállningar 1980. Supplement. Apoteks-
bolaget.
9) Pedoe HDT. Digoxin prescribing in general
practice 1967-1977. Lancet 1978; 2: 931-3.
10) Johnson GD, McDevitt DG. Is maintenance
digoxin necessary in patients with sinus
rhythm? Lancet 1979; 1: 567-70.
11) Dall JLC. Maintenance Digoxin in Elderly
Patients. Br Med J 1970; 2: 705-6.
12) Boman K, Möllerberg H. Digoxinintoxikation i
ett oselekterat patientmaterial. Lakartidningen
1979;76:4108-10.
13) Beller GA, Smith TW, Abelmann WH, Haber E,
Hood WB. Digitalis Intoxication. A Prospective
Clinical Study with Serum Level Correlations.
N Engl J Med 1971; 284; 989-97.
14) Guz A, McHaffie D. The use of digitalis
glycosides in sinus rhythm. Ed. review. Clin
Science and Mol Medicine 1978; 55: 417-21.
15) Johnson GD, McDebitt DG. Digoxin complian-
ce in patients from general practice. Br J Clin
Pharmac 1978; 6: 339-43.
16) Liverpool Therapeutics Group: Use of digitalis
in general practice. Br Med J 1978; 2: 673-5.
17) Lindenbaum J, Rund DG, Butler VP, Tse-Eng D,
Saha JR. Inactivation of digoxin by the gut
flora: Reversal by antibiotic therapy. N Engl J
Med 1981;305: 789-94.
18) Brown DD, Juhl RP. Decreased Bioavailability
of Digoxin due to Antacids and Kaolin-Pectin.
N Engl J Med 1976; 295: 1034-7.
19) Jogestrand T. Influence of every day physical
activity on the serum digoxin concentration in
digoxin treated patients. Clin Physiol 1981; 1:
209-14.
20) Petersen I. Lyfjamáladeild Heilbrigðisráðu-
neytis Islands: Persónulegar upplýsingar, janúar
1982.
21) Pórarinsson S, Sigurðsson G, Jóelsson H.
Háþrýstingur á heilsugæslustöð II. Læknablaðið
1981;67:257-63.
22) Dobbs SM, Kenyon WI, Dobbs RJ. Maintenan-
ce digoxin after an episode of heart failure:
Placebo-controlled trial in outpatients. Br Med
J 1977; 1:749-52.
23) Hull SM, MacKintosh A. Discontinuation of
maintenance digoxin therapy in general practi-
ce. Lancet 1977; 2: 1054-5.
24) Krakauer R, Petersen B. The effects of disconti-
nuing maintenance digoxin therapy; A study of
elderly cardiac patients in sinus rhythm. Dan
Med Bull 1979; 26: 10-3.
25) Boman K, Allgulander S, Skoglund M. Is Main-
tenance Digoxin Necessary in Geriatric Pa-
tients? Acta Med Scand 1981; 210: 493-5.
26) Cohn JN. Indications for Digitalis Therapy.
JAMA 1974;229: 1911-4.
27) Taggart AJ, McDevitt DG. Digitalis: Its Place in
Modern Therapy. Drugs 1980; 20: 398-404.
28) Opie LH. Digitalis and sympathomimetic stimu-
lants. Lancet 1980; 1:912-8.
29) Arnold SB, Byrd RC, Meister W et al. Long-
term digitalís therapy improves left ventricular
function in heart failure. N Engl J Med 1980;
303: 1443-8.
30) McHaffie D, Purcell H, Mitchell-Heggs P, Guz
A. The Clinical Value of Digoxin in Patients
with Heart Failure and Sinus Rhythm. Quart J
Med 1978; N.S. 47: 401-19.